Cargando…
Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice
BACKGROUND: Lipids are known to play crucial roles in the development of life-style related risk factors such as obesity, dyslipoproteinemia, hypertension and diabetes. The first selective cannabinoid-1 receptor blocker rimonabant, an anorectic anti-obesity drug, was frequently used in conjunction w...
Autores principales: | Hu, Chunxiu, Wei, Heng, van den Hoek, Anita M., Wang, Mei, van der Heijden, Rob, Spijksma, Gerwin, Reijmers, Theo H., Bouwman, Jildau, Wopereis, Suzan, Havekes, Louis M., Verheij, Elwin, Hankemeier, Thomas, Xu, Guowang, van der Greef, Jan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096625/ https://www.ncbi.nlm.nih.gov/pubmed/21611179 http://dx.doi.org/10.1371/journal.pone.0019423 |
Ejemplares similares
-
Lipidomics Reveals Multiple Pathway Effects of a Multi-Components Preparation on Lipid Biochemistry in ApoE*3Leiden.CETP Mice
por: Wei, Heng, et al.
Publicado: (2012) -
Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
por: Kühnast, Susan, et al.
Publicado: (2013) -
Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice
por: Schilperoort, Maaike, et al.
Publicado: (2020) -
Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice
por: Jongejan, Yvonne K., et al.
Publicado: (2021) -
Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice
por: van Eenige, Robin, et al.
Publicado: (2021)